Description
There is limited knowledge sharing on pediatric musculoskeletal ultrasound and so the goal of this talk is to help improve this and thereby improve the attendees' breadth of knowledge on this topic.
This lecture, will be a Part 2 talk following to our recorded Part 1 Member May Lecture on the fundamentals of pediatric MSK ultrasound.
During this Part 2 virtual session, a handful of experts in pediatric musculoskeletal ultrasound across the country, with different training backgrounds, will share their collection of interesting cases they have personally come across, with plenty of images to enrich their case presentations. This lecture will also be a required prerequisite to a possible hands on pediatric MSK US course at the AAPMR Annual Assembly this year.
Learning Objectives
After completing this live activity, the participant should be able to:
- Gain exposure to concrete examples on the usefulness of pediatric MSK Ultrasound
- Gain exposure to concrete examples that demonstrate pitfalls when using pediatric MSK Ultrasound
- Increase their awareness of different kinds of pediatric MSK cases, especially those with uncommon presentations or findings
- Ask any questions to experienced pediatric MSK sonographers during the concluding panel discussion
Accreditation Statement
The American Academy of Physical Medicine and Rehabilitation (AAPM&R) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
CME Credit Designation
The American Academy of Physical Medicine and Rehabilitation (AAPM&R) designates this live activityfor a maximum of 1.00 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Disclosure Statement
In accordance with ACCME’s Standards for Integrity and Independence in Accredited Continuing Education, AAPM&R requires all individuals who are in a position to affect the strategic direction of AAPM&R and/or control the content of an educational activity to disclose all financial relationships with any ineligible company within the last 24 months. The ACCME defines an “ineligible company” as any entity whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
Disclosures are made in written form prior to the start of the educational activity, and any potential conflicts of interest that exist are mitigated prior to the start of the activity through AAPM&R’s Conflict of Interest Disclosure and Resolution Policy Process. Individuals in a position to affect the strategic direction of AAPM&R and/or control content and their disclosed financial relationships are listed below.
No other planners, faculty, or individuals in control of content disclosed any relevant financial relationships.
Principle Faculty
Name, Credential(s): Company Name, Nature of financial relationship;
Ami Hampole DO, FAAPMR, FAANEM, RMSK - Nothing to Disclose
Jacob Jones, MD, FAAP, RMSK - Nothing to Disclose
Christopher Newman, MD, MS, PhD, FACR - Nothing to Disclose
Jeremy Roberts, MD, FAAPMR, CAQSM - Nothing to Disclose
Randon Hall, MD, MBA, FAAP, FAQSM, RMSK - Nothing to Disclose
John Cianca, MD, FAAPMR, CAQSM, RMSK - Nothing to Disclose
AAPM&R Medical Education Committee
Name, Credential(s): Company Name, Nature of financial relationship
Rachel Brakke Holman, MD - Nothing to Disclose
Sarah M. Eickmeyer, MD - Nothing to Disclose
Chelsea D. Frost, MD, MS - Nothing to Disclose
David J. Haustein, MBA,MD,MBA - Relationships to Disclose
Sarah K. Hwang, MD - Nothing to Disclose
Ravi E. Kasi, MD - Nothing to Disclose
Caroline Pupke, DO - Nothing to Disclose
Monica E. Rho, MD - Nothing to Disclose
McCasey R. Smith, MD - Nothing to Disclose
Jennifer A. Soo Hoo, MD - Nothing to Disclose
Brionn K. Tonkin, MD - Nothing to Disclose
Stephanie Tow, MD - Nothing to Disclose
Justin L. Weppner, DO - Nothing to Disclose
Alexandra G. Wolfe, DO - Nothing to Disclose
FDA Disclosures
All faculty members for this activity have disclosed they do not intend to discuss or demonstrate any pharmaceutical or medical device for which FDA clearance has not been approved.